Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced ...
Credit: Getty Images We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS. Artificial ...
Women who have close family members with endocrine diseases, including type 2 diabetes, thyroid diseases and polycystic ovary syndrome (PCOS), are at higher risk of pregnancy loss, a new study has ...
A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug ...
Confo Therapeutics NV has secured a 2-year €1 million (US$1.2 million) grant from Flanders Innovation & Entrepreneurship ...
Neurocrine Biosciences’ Crenessity is now FDA approved for treating classic congenital adrenal hyperplasia (CAH), a rare and potentially fatal endocrine disorder. The approval comes with a priority ...
Testosterone is the quintessential male hormone (androgen), and it’s a busy one, helping to regulate intimate function, ...
Women who have close family members with endocrine diseases, including type 2 diabetes, thyroid diseases and polycystic ovary syndrome (PCOS), are at higher risk of pregnancy loss, a new study has ...
Postmenopausal women with multiple sclerosis (MS) have a higher rate of comorbidities than premenopausal women.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback